The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

被引:2
|
作者
Dobler, Claudia C. [1 ]
机构
[1] Mayo Clin, Evidence Based Practice Ctr, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA
基金
英国医学研究理事会;
关键词
D O I
10.1183/20734735.026418
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:333 / 335
页数:3
相关论文
共 50 条
  • [21] Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
    Ismaila, Afisi S.
    Risebrough, Nancy
    Schroeder, Melanie
    Shah, Dhvani
    Martin, Alan
    Goodall, Emma C.
    Ndirangu, Kerigo
    Criner, Gerard
    Dransfield, Mark
    Halpin, David M. G.
    Han, MeiLan K.
    Lomas, David A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2681 - 2695
  • [22] Cost-effectiveness of a Single-Inhaler Triple Therapy Versus a Dual Bronchodilator for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Australia
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Thrasis, A.
    Schembri, S.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial
    Amanda Vallejo, Laura
    Paly, Victoria
    Martin, Alan
    Risebrough, Nancy
    Abreu, Catarina
    Izquierdo, Jose Luis
    Riesco, Juan Antonio
    Soler-Cataluna, Juan Jose
    Ismaila, Afisi S.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [24] Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management
    Averell, Carlyne M.
    Busse, William W.
    Abbott, Carl B.
    Germain, Guillaume
    MacKnight, Sean D.
    Jung, Young
    Duh, Mei Sheng
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11): : 2904 - +
  • [25] CHARACTERISTICS OF EARLY ADOPTERS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL: A SINGLE-INHALER TRIPLE THERAPY FOR COPD
    Pollack, Michael
    Noorduyn, Stephen G.
    Lee, Inyoung
    Sun, Kainan K. S.
    Zhao, Xiaohui
    Kruse, Lisa K.
    Feigler, Norbert
    Patel, Sushma M.
    Near, Aimee
    CHEST, 2022, 162 (04) : 1887A - 1888A
  • [26] Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
    Paly, Victoria Federico
    Amanda Vallejo-Aparicio, Laura
    Martin, Alan
    Luis Izquierdo, Jose
    Riesco, Juan Antonio
    Jose Soler-Cataluna, Juan
    Abreu, Catarina
    Biswas, Chandroday
    Ismaila, Afisi S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 3097 - 3109
  • [27] RISK OF EXACERBATION AND PNEUMONIA WITH SINGLE INHALER TRIPLE VERSUS DUAL THERAPY IN IMPACT
    Dransfield, M.
    Crim, C.
    Criner, G.
    Halpin, D. M. G.
    Han, M. K.
    Jones, C. E.
    Kilbride, S.
    Lange, P.
    Lipson, D. A.
    Lomas, D. A.
    Martinez, F.
    Singh, D.
    Wise, R.
    THORAX, 2018, 73 : A236 - A236
  • [28] Risk of exacerbation and pneumonia with single inhaler triple versus dual therapy in IMPACT
    Dransfield, Mark
    Crim, Courtney
    Criner, Gerard
    Halpin, David
    Han, Meilan
    Jones, C. Elaine
    Kilbride, Sally
    Lange, Peter
    Lipson, David
    Lomas, David
    Martinez, Fernando
    Singh, David
    Wise, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [29] BUDGET IMPACT ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYA') VERSUS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE FROM PUBLIC HEALTH SYSTEM PERSPECTIVE IN CHILE
    Balmaceda, C.
    Abbott, T.
    Espinoza, M. A.
    VALUE IN HEALTH, 2020, 23 : S354 - S354
  • [30] Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbation
    Ismaila, A.
    Wood, R.
    Czira, A.
    Banks, V
    Camidge, L.
    Massey, O.
    Sharma, R.
    Compton, C.
    Rothnie, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60